Kainos Medicine

카이노스메드 · 284620

Industrials Commercial Services · KOSDAQ

Small-cap

Market cap US$26.1M (₩36B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$849K
▲ +98.5% YoY
Operating profit · FY2025
−US$4.7M
Loss narrowed
Net income · FY2025
−US$5.6M
Loss narrowed

Revenue

  • FY2023US$193.7K
  • FY2024US$427.8K
  • FY2025US$849K

Operating profit

  • FY2023−US$12.2M
  • FY2024−US$8.9M
  • FY2025−US$4.7M

Net income

  • FY2023−US$11M
  • FY2024−US$8.8M
  • FY2025−US$5.6M

Key ratios (FY2025)

ROE
-169.1%
Debt/Eq
43.8%
Op. margin
-549.6%
Net margin
-664.4%
Rev. YoY
▲ +98.5%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.